- Cantharidin suppresses hepatocellular carcinoma development by regulating EZH2/H3K27me3-dependent cell cycle progression and antitumour immune response
Jia Yan et al, 2023, BMC Complementary Medicine and Therapies CrossRef - Cell metabolomics study on synergistic anti‐hepatocellular carcinoma effect of Aidi injection combined with doxorubicin
Yanli Wang et al, 2022, Biomedical Chromatography CrossRef - Anticancer Attributes of Cantharidin: Involved Molecular Mechanisms and Pathways
Faiza Naz et al, 2020, Molecules CrossRef - Breaking Glucose Transporter 1/Pyruvate Kinase M2 Glycolytic Loop Is Required for Cantharidin Inhibition of Metastasis in Highly Metastatic Breast Cancer
Yanhong Pan et al, 2019, Frontiers in Pharmacology CrossRef - Hepatotoxic mechanism of cantharidin: insights and strategies for therapeutic intervention
Dian Jin et al, 2023, Frontiers in Pharmacology CrossRef - Role of the PP2A Pathway in Cholangiocarcinoma: State of the Art and Future Perspectives
Ion Cristóbal et al, 2022, Cancers CrossRef